Found 229 matching trials
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia PHASE2 The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) PHASE1 Patients enrolled on this study will have received a stem cell transplant. ...
Show More Location
Texas Childrens Hospital
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation PHASE1 In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg an...
Show More Location
UF Health Shands Children's Hospital
Learn More & Join Trial
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL PHASE3 With this protocol the ALL-SCT BFM international study group wants
* to ev...
Show More Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. PHASE2 RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Show More Location
Children's Memorial Hospital
Learn More & Join Trial
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies NA This clinical trial studies fludarabine phosphate and total-body radiation ...
Show More Location
University of Arizona Health Sciences Center
Learn More & Join Trial
90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of yttrium Y 90 a...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) PHASE2 The immune system has offensive and defensive capacities. In bone marrow tr...
Show More Location
Katholieke Universiteit Leuven
Learn More & Join Trial
Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer PHASE2 RATIONALE: Giving low doses of chemotherapy, such as cyclophosphamide and f...
Show More Location
NIH - Warren Grant Magnuson Clinical Center
Learn More & Join Trial